Adam Robinson

Dr. Adam Robinson

Senior Manager, 14C Enabled Drug Development, Scientific Consulting

About

Dr. Adam Robinson-Miller has more than a decade of experience in the pharmaceutical and OTC environments, with particular focus on formulation design, DoE and QbD strategies for innovative drug products. More recently Dr Robinson-Miller has become one of our established SME’s in the design of Human Mass Balance or ADME studies, supporting Biotechs and Large Pharma with their ADME strategy.

Over the course of his career, Adam has worked across multiple drug modalities and across the globe to support new medicines to market.

Adam also was a guest lecturer at Hull University for the Masters in Pharmacology and Drug Development.

Adam holds an MChem in Chemistry with Medicinal Chemistry from Newcastle University, and a PhD in Chemistry from Northumbria University.

Clinical Pharmacology Services
Clinical Pharmacology

Clinical Pharmacology Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More